[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366397-105":59,"doc-detail-366397-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lncrna-slc7a11ar-promotes-lung-adenocarcinoma-progression-by-inhibiting-ferroptosis-via-promoting-slc7a11-expression","LncRNA SLC7A11AR promotes lung adenocarcinoma progression by inhibiting ferroptosis via promoting SLC7A11 expression","","Non-small cell lung cancer (NSCLC) remains difficult to treat despite advances in targeted and immune therapies, creating demand for novel biomarkers and regulators. This study identifies the inflammatory-pathway induced human lncRNA SLC7A11AR, which is highly expressed in lung adenocarcinoma (LUAD) and linked to poorer prognosis. Functional depletion of SLC7A11AR suppresses tumor growth, migration, and xenograft formation by promoting ferroptosis. Mechanistically, SLC7A11AR directly binds miR-150-5p, relieving repression of SLC7A11, a key ferroptosis inhibitor, and ASO-based inhibition reduces progression alone or with a ferroptosis agonist.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lncrna-slc7a11ar-promotes-lung-adenocarcinoma-progression-by-inhibiting-ferroptosis-via-promoting-slc7a11-expression/366397/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lncrna-slc7a11ar-promotes-lung-adenocarcinoma-progression-by-inhibiting-ferroptosis-via-promoting-slc7a11-expression/366397.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SLC7A11AR and where is it expressed in lung cancer?","Question",{"text":112,"@type":113},"SLC7A11AR is a human-specific long non-coding RNA induced by the inflammatory pathway. It is highly expressed in lung adenocarcinoma (LUAD) cell lines but not in lung squamous cell carcinoma (LUSC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does SLC7A11AR affect tumor progression?",{"text":117,"@type":113},"Higher SLC7A11AR expression correlates with worse clinical prognosis. Depleting SLC7A11AR restrains proliferation and migration and reduces xenograft tumor formation by promoting ferroptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the proposed molecular mechanism involving miR-150-5p and SLC7A11?",{"text":121,"@type":113},"Bioinformatics and dual luciferase assays show SLC7A11AR binds directly to miR-150-5p, weakening miR-150-5p inhibition of SLC7A11. This axis enhances oncogenic activity in LUAD, with SLC7A11 upregulated while miR-150-5p is downregulated in tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366397,1790196829,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2025; 21(10): 4549-4566. doi: 10.7150/ijbs.112233  \nResearch Paper  \nLncRNA SLC7A11AR promotes lung adenocarcinoma progression by inhibiting ferroptosis via promoting SLC7A11 expression  \nHaoqing Zhai1,2,‡, Xudong Xiang3,‡, Jun Pu3,‡, Xiaoqun Niu3,‡, Jie Gao4, Dengcai Mu1,2, Jia Du1,2, Yao Li1,2, Laihao Qu4, Baiyang Liu4,􀀍, Yongbin Chen1,2,4,􀀍, Cuiping Yang5,6,􀀍  \n1. State Key Laboratory of Genetic Evolution & Animal Models, the Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China.  \n2. Kunming College of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, China.  \n3. Kunming Medical University, Kunming, Yunnan 650118, China.  \n4. The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.  \n5. The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.  \n6. Shanghai Key Laboratory of Embryo Original Diseases, Shanghai 200030, China.  \n‡ These authors contributed equally to this work.  \n􀀍 Corresponding authors: Cuiping Yang: [cuipingyang@sjtu.edu.cn](cuipingyang@sjtu.edu.cn). Yongbin Chen: [ybchen@mail.kiz.ac.cn](ybchen@mail.kiz.ac.cn). Baiyang Liu: [zzuliubaiyang@163.com](zzuliubaiyang@163.com).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.02.15; Accepted: 2025.06.20; Published: 2025.07.11  \nAbstract  \nNon-small cell lung cancer (NSCLC) is a prevalent classification of human lung cancer with a variety of clinical pathological features. Several key factors and associated signaling pathways have played pivotal roles in the progression of NSCLC and serve as potential therapeutic targets. However, the therapeutic efficacy is still limited, and novel biomarkers and key regulators are inevitable. We found a human-specific long non-coding RNA (lncRNA, ENST00000504300) induced by the inflammatory pathway, termed SLC7A11AR (SLC7A11 associated lncRNA), which was highly expressed in lung adenocarcinoma (LUAD) cell lines but not in lung squamous cell carcinoma (LUSC). Our research showed that higher SLC7A11AR expression correlates with a poorer clinical prognosis. Depleting SLC7A11AR restrains tumor cell proliferation, migration, and xenograft tumor formation by promoting ferroptosis. Bioinformatic analysis and dual luciferase reporter assays revealed that SLC7A11AR binds directly to miR-150-5p, weakening the inhibition on its downstream target SLC7A11, a key ferroptosis inhibitor in NSCLC. In cancerous tissues, SLC7A11AR was upregulated, while miR-150-5p was downregulated compared to control tissues. Enforced miR-150-5p expression inhibited tumor growth. Moreover, ASOs against SLC7A11AR alone or with a ferroptosis agonist significantly suppressed tumor progression. Our results suggest that the SLC7A11AR/miR-150-5p/SLC7A11 axis plays an oncogenic role in LUAD development and has the potential to be novel therapeutic targets, presenting new opportunities for LUAD treatment in the future.  \nKeywords: SLC7A11AR, miR-150-5p, SLC7A11, ferroptosis, lung adenocarcinoma (LUAD)  \nIntroduction  \nLung cancer, which initiates within the bronchial tubes or lung glands, ranks among the most prevalent cancers globally, both in terms of its occurrence frequency and fatality rate, accounting for 12.4% and 18.7%, respectively[1] . Lung cancer is mainly categorized into NSCLC (non-small cell lung cancer) and SCLC (small cell lung cancer) . NSCLC, which  \nrepresents the majority of cases, is further divided into LUAD (lung adenocarcinoma), LUSC (squamous cell carcinoma), an","cbCaiaruAcElMZ8N","https://ap.wps.com/l/cbCaiaruAcElMZ8N","pdf",15218197,18,"English","# Abstract\n# Introduction","[{\"question\":\"What is SLC7A11AR and where is it expressed in lung cancer?\",\"answer\":\"SLC7A11AR is a human-specific long non-coding RNA induced by the inflammatory pathway. It is highly expressed in lung adenocarcinoma (LUAD) cell lines but not in lung squamous cell carcinoma (LUSC).\"},{\"question\":\"How does SLC7A11AR affect tumor progression?\",\"answer\":\"Higher SLC7A11AR expression correlates with worse clinical prognosis. Depleting SLC7A11AR restrains proliferation and migration and reduces xenograft tumor formation by promoting ferroptosis.\"},{\"question\":\"What is the proposed molecular mechanism involving miR-150-5p and SLC7A11?\",\"answer\":\"Bioinformatics and dual luciferase assays show SLC7A11AR binds directly to miR-150-5p, weakening miR-150-5p inhibition of SLC7A11. This axis enhances oncogenic activity in LUAD, with SLC7A11 upregulated while miR-150-5p is downregulated in tumors.\"}]","LncRNA SLC7A11AR promotes lung adenocarcinoma progression by inhibiting ferroptosis via promoting SLC7A11 expression | PDF",1790165254,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9df1fb9b89c8f77aa1e97d25f41f5542.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36eb273171f129db37010074a1121c05.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef8e52f0efc63bba736aecac73d57b94.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64a3eb4509526a98b75183575a713ef2.webp",980,1268]